Democratic Republic of the Congo

Last Updated 21 April 2021.

1 Vaccine Approved for Use in Democratic Republic of the Congo

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 91 countries

  24 trials in 15 countries

  Non Replicating Viral Vector

0 Vaccines in Clinical Trials in Democratic Republic of the Congo